120 related articles for article (PubMed ID: 11196310)
1. Generation and characterization of recombinant vascular targeting agents from hybridoma cell lines.
Gottstein C; Wels W; Ober B; Thorpe PE
Biotechniques; 2001 Jan; 30(1):190-4, 196, 198 passim. PubMed ID: 11196310
[TBL] [Abstract][Full Text] [Related]
2. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex.
Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA
Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-toxin conjugate specifically inhibits KDR/flk-1-positive endothelial cell proliferation in vitro and angiogenesis in vivo.
Ramakrishnan S; Olson TA; Bautch VL; Mohanraj D
Cancer Res; 1996 Mar; 56(6):1324-30. PubMed ID: 8640821
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
[TBL] [Abstract][Full Text] [Related]
5. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
[TBL] [Abstract][Full Text] [Related]
6. VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.
Brekken RA; Thorpe PE
J Control Release; 2001 Jul; 74(1-3):173-81. PubMed ID: 11489493
[TBL] [Abstract][Full Text] [Related]
7. Treatment for malignant pleural effusion of human lung adenocarcinoma by inhibition of vascular endothelial growth factor receptor tyrosine kinase phosphorylation.
Yano S; Herbst RS; Shinohara H; Knighton B; Bucana CD; Killion JJ; Wood J; Fidler IJ
Clin Cancer Res; 2000 Mar; 6(3):957-65. PubMed ID: 10741721
[TBL] [Abstract][Full Text] [Related]
8. Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells.
Kanno S; Oda N; Abe M; Terai Y; Ito M; Shitara K; Tabayashi K; Shibuya M; Sato Y
Oncogene; 2000 Apr; 19(17):2138-46. PubMed ID: 10815805
[TBL] [Abstract][Full Text] [Related]
9. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis.
Oh H; Takagi H; Otani A; Koyama S; Kemmochi S; Uemura A; Honda Y
Proc Natl Acad Sci U S A; 2002 Jan; 99(1):383-8. PubMed ID: 11756651
[TBL] [Abstract][Full Text] [Related]
10. Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteins.
Backer MV; Backer JM
Bioconjug Chem; 2001; 12(6):1066-73. PubMed ID: 11716701
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias.
Dias S; Hattori K; Heissig B; Zhu Z; Wu Y; Witte L; Hicklin DJ; Tateno M; Bohlen P; Moore MA; Rafii S
Proc Natl Acad Sci U S A; 2001 Sep; 98(19):10857-62. PubMed ID: 11553814
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor as a marker of tumor endothelium.
Brekken RA; Huang X; King SW; Thorpe PE
Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ.
Takayama K; Ueno H; Nakanishi Y; Sakamoto T; Inoue K; Shimizu K; Oohashi H; Hara N
Cancer Res; 2000 Apr; 60(8):2169-77. PubMed ID: 10786681
[TBL] [Abstract][Full Text] [Related]
15. Endothelial receptor tyrosine kinases involved in angiogenesis.
Mustonen T; Alitalo K
J Cell Biol; 1995 May; 129(4):895-8. PubMed ID: 7538139
[No Abstract] [Full Text] [Related]
16. Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma.
Strizzi L; Catalano A; Vianale G; Orecchia S; Casalini A; Tassi G; Puntoni R; Mutti L; Procopio A
J Pathol; 2001 Apr; 193(4):468-75. PubMed ID: 11276005
[TBL] [Abstract][Full Text] [Related]
17. Receptor links blood vessels, axons.
Roush W
Science; 1998 Mar; 279(5359):2042. PubMed ID: 9537914
[No Abstract] [Full Text] [Related]
18. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
[TBL] [Abstract][Full Text] [Related]
19. Expression of VEGF-C and activation of its receptors VEGFR-2 and VEGFR-3 in trophoblast.
Dunk C; Ahmed A
Histol Histopathol; 2001 Apr; 16(2):359-75. PubMed ID: 11332691
[TBL] [Abstract][Full Text] [Related]
20. The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.
Béliveau R; Gingras D; Kruger EA; Lamy S; Sirois P; Simard B; Sirois MG; Tranqui L; Baffert F; Beaulieu E; Dimitriadou V; Pépin MC; Courjal F; Ricard I; Poyet P; Falardeau P; Figg WD; Dupont E
Clin Cancer Res; 2002 Apr; 8(4):1242-50. PubMed ID: 11948139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
